D1 Medical Technology Overview
- Year Founded
-
2019
- Status
-
Private
- Latest Deal Type
-
Later Stage VC
- Investors
-
5
D1 Medical Technology General Information
Description
Developer and manufacturer of organoid technology intended to support regeneration medicine and transplantation. The company develops organoids to improve the development of disease diagnosis and treatment, new drug screening, and tumor marker identification, providing accurate, efficient and high-quality organoid models for new drug development and personalized treatments.
Contact Information
Website
www.d1med.comCorporate Office
- 3rd Floor
- No. 665 Zhangjiang Road, China Pilot Free Trade Zone
- Shanghai
- China
Corporate Office
- 3rd Floor
- No. 665 Zhangjiang Road, China Pilot Free Trade Zone
- Shanghai
- China
D1 Medical Technology Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Later Stage VC | 19-Dec-2024 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 14-Oct-2021 | Completed | Generating Revenue | |||
| 1. Early Stage VC | 08-Feb-2021 | Completed | Generating Revenue |
D1 Medical Technology Patents
D1 Medical Technology Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2024026676-A1 | Preparation system and preparation method for vitroorganospheres with core-shell structure, and total system | Inactive | 02-Aug-2022 | ||
| WO-2024027717-A1 | Total system and method for full automatic preparation, sorting, and distribution and culturing of in-vitro organ microsphere | Inactive | 02-Aug-2022 | ||
| WO-2023274338-A1 | Culture medium, method, and reagent kit for rapidly culturing tumor organoids | Inactive | 01-Jul-2021 | ||
| WO-2022241929-A1 | Method for measuring maximum cross-sectional area of organoid, and application thereof | Inactive | 17-May-2021 | ||
| WO-2022227289-A1 | Method for detecting sensitivity of organoid to macromolecular drug with sandwich culture system | Inactive | 26-Apr-2021 | G01N33/5011 |
D1 Medical Technology Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Zhejiang Huarui Holdings | Growth/Expansion | Minority | ||
| Delian Capital | Venture Capital | Minority | ||
| Kunnuo Tianqin Venture Capital | Corporate Venture Capital | Minority | ||
| Shanghai Guofang Fund of Funds Equity Investment Management | Fund of Funds | Minority | ||
| Co-Win Ventures | Venture Capital | Minority |
D1 Medical Technology FAQs
-
When was D1 Medical Technology founded?
D1 Medical Technology was founded in 2019.
-
Where is D1 Medical Technology headquartered?
D1 Medical Technology is headquartered in Shanghai, China.
-
What industry is D1 Medical Technology in?
D1 Medical Technology’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is D1 Medical Technology a private or public company?
D1 Medical Technology is a Private company.
-
What is D1 Medical Technology’s current revenue?
The current revenue for D1 Medical Technology is .
-
How much funding has D1 Medical Technology raised over time?
D1 Medical Technology has raised $18.6M.
-
Who are D1 Medical Technology’s investors?
Zhejiang Huarui Holdings, Delian Capital, Kunnuo Tianqin Venture Capital, Shanghai Guofang Fund of Funds Equity Investment Management, and Co-Win Ventures have invested in D1 Medical Technology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process